相关实验视频

Updated: May 13, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

13.9K

PFS24作为新诊断的中枢神经系统原发性淋巴瘤患者的预后里程碑

Vanja Zeremski1, Tobias R Haage2, Hanno M Witte3

  • 1Department of Hematology, Oncology and Cell Therapy, Medical Faculty, Otto von Guericke University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany. vanja.zeremski@med.ovgu.de.

Journal of hematology & oncology
|April 24, 2025
PubMed
概括

24个月的无进展生存率 (PFS24) 是初级中枢神经系统淋巴瘤 (PCNSL) 的关键预后标志物. 实现PFS24表明预后有利,而失败表明结果不佳,指导治疗策略.

关键词:
总体生存率 总体生存率PFS24 PFS24 PFS24 PFS24 PFS24 PFS24 PFS24 PFS24 PFS24 PFS24 PFS24主要中枢神经系统淋巴瘤

更多相关视频

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

744
Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.8K

相关概念视频